Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT07051005

Feasibility of a Tailored Online Self-compassion Intervention

Feasibility of a Tailored Online Self-compassion Intervention — Recruiting • Non-phase study • Diabetes / Metabolic • NCT07051005.

📅 25 Mar 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07051005
Sponsor
Canterbury Christ Church University
Start
2025-06-18
ClinicaliQ Trial Snapshot
  • Feasibility of a Tailored Online Self-compassion Intervention — Recruiting • Non-phase study • Diabetes / Metabolic • NCT07051005.
  • The goal of this clinical trial is to examine the feasibility and acceptability of an online programme that is based on Compassionate Mind Training (CMT) over four-weeks. The programme intends to share information and strategies to reduce diabetes distress, self-criticism, and shame,….
  • Sponsor: Canterbury Christ Church University.

Verify eligibility, endpoints and current status on the original source registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The goal of this clinical trial is to examine the feasibility and acceptability of an online programme that is based on Compassionate Mind Training (CMT) over four-weeks. The programme intends to share information and strategies to reduce diabetes distress, self-criticism, and shame, and improve physical health in people who have Type 1 and Type 2 Diabetes Mellitus. Lead Sponsor: Canterbury Christ Church University Start Date: 2025-06-18 Primary Completion: 2026-05-01

Eligibility Snapshot
  • : * 18 years old or older. * Diagnosed with Type 1 or Type 2 diabetes by a clinician in the NHS more than one year ago. * Self-managing theircondition. * Identified by their NHS team as needing support with their mental health due to diabetes-related distress.

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
Teplizumab for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetes
Diabetes / Metabolic · 09 Jul 2026
Teplizumab is recommended for people aged 8 years and over with stage 2 type 1 diabetes to delay progression to stage 3;…
View guideline →
Clinical Brief
Obesity rates have doubled in England since 1993 – what’s going on?
Diabetes / Metabolic · BBC Health · 07 Aug 2026
Obesity prevalence in England has doubled since 1993, representing an additional 7 million adults—a substantial public health burden with significant implications for…
View brief →
Guideline
Semaglutide for Managing Overweight and Obesity (NICE TA875)
Diabetes / Metabolic · 27 Mar 2026
Initiate semaglutide only in specialist obesity services or via shared care with clear primary-secondary care protocols for adults with BMI ≥30 kg/m²…
View guideline →
Clinical Brief
Rise in women in their 20s developing Type 2 diabetes
Diabetes / Metabolic · BBC Health · 22 Jul 2026
Young women in their 20s in England are developing type 2 diabetes at increasing rates, representing a shift in disease epidemiology traditionally…
View brief →
Clinical Brief
More young women in their 20s are getting type 2 diabetes
Diabetes / Metabolic · BBC Health · 22 Jul 2026
Type 2 diabetes incidence is rising significantly in women aged in their 20s in England, requiring heightened clinical vigilance for early detection…
View brief →
Guideline
Type 1 Diabetes in Adults: Diagnosis and Management (NICE NG17)
Diabetes / Metabolic · 25 Mar 2026
Offer multiple daily injection (MDI) basal-bolus insulin regimen as first-line treatment for all adults with type 1 diabetes, with continuous subcutaneous insulin…
View guideline →